These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 30651362)

  • 1. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.
    Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
    Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
    J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.
    Holmes DL; Vogt DT; Lagunoff M
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
    Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
    J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells.
    Haddad CO; Kalt I; Shovman Y; Xia L; Schlesinger Y; Sarid R; Parnas O
    Virol J; 2021 Mar; 18(1):56. PubMed ID: 33731154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
    Liang Z; Qin Z; Riker AI; Xi Y
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
    Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
    J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome Maintenance Proteins Cooperate with LANA during the G
    Dabral P; Uppal T; Rossetto CC; Verma SC
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.
    Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
    An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
    J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
    Staudt MR; Dittmer DP
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
    Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
    J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.
    Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ
    J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.